Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma.
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma. Blood Adv. 2023 03 14; 7(5):768-777.
View in:
PubMed
subject areas
Humans
Lymphocytes
Multiple Myeloma
Neurotoxicity Syndromes
authors with profiles
Andrzej Jakubowiak